Kamada KMDA
NASDAQ KMDA
$8.69 +0.07 (+0.87%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kamada (KMDA) EBITDA (2012 - 2026)

Updated

Kamada (KMDA) recorded EBITDA of $13.4 million in the quarter ended Jun 30, 2026, up 23.9% from $10.82 million a year earlier and up 24.0% from the prior quarter.

Analysis

Kamada (KMDA) EBITDA (2012 - 2026) Analysis & Trends

On a TTM basis, Kamada's EBITDA came in at $43.13 million as of Jun 30, 2026, up 8.0% year-over-year; for the year ended Dec 31, 2025, it was $41.15 million, up 21.5% from the prior year.

  • Annual EBITDA has increased for four straight years, with a five-year compound annual growth rate of 11.3% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, EBITDA came in at $33.86 million in the year ended Dec 31, 2024 (+48.6%), $22.78 million in the year ended Dec 31, 2023 (+36.5%), $16.69 million in the year ended Dec 31, 2022 (+239.6%) and $4.91 million in the year ended Dec 31, 2021 (-79.6%).
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly EBITDA since the quarter ended Dec 31, 2018.
  • On a year-over-year basis, EBITDA rose in six of the last eight quarters, with growth averaging 22.4%.
  • Peak year-over-year performance for EBITDA in the last five years was growth of 660.8% in the quarter ended Jun 30, 2023, against a decline of 95.2% in the quarter ended Sep 30, 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $10.8 million (quarter ended Mar 31, 2026), $7.35 million (quarter ended Dec 31, 2025) and $11.58 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 9.10 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 8.33 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 999.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 5.09 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.63 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -9.70 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.89 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.30 Bn
10 Kamada 497.25 Mn 206.31 Mn 22.47 Mn 13.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.40 Mn
Mar 31, 2026 10.80 Mn
Dec 31, 2025 7.35 Mn
Sep 30, 2025 11.58 Mn
Jun 30, 2025 10.82 Mn
Mar 31, 2025 11.41 Mn
Dec 31, 2024 9.18 Mn
Sep 30, 2024 8.54 Mn
Jun 30, 2024 8.87 Mn
Mar 31, 2024 7.28 Mn
Dec 31, 2023 5.98 Mn
Sep 30, 2023 7.55 Mn
Jun 30, 2023 5.84 Mn
Mar 31, 2023 3.41 Mn
Dec 31, 2022 7.03 Mn
Sep 30, 2022 5.62 Mn
Jun 30, 2022 767,000.00
Mar 31, 2022 3.27 Mn
Dec 31, 2021 -1.31 Mn
Sep 30, 2021 436,000.00
API Access

Kamada EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=KMDA&period=max&api_key=YOUR_API_KEY